Participate in Phase 3 trials to protect against Covid: Bharat Biotech By IANSPublished December 25, 2020 · Updated December 25, 2020
Bharat Biotech again applies for vaccine’s emergency approval By IANSPublished December 24, 2020 · Updated December 24, 2020
Inactivated vaccines are safest with lesser adverse reactions: Bharat Biotech By IANSPublished December 21, 2020 · Updated December 21, 2020
India to produce 300 million doses of Sputnik vaccine By IANSPublished December 19, 2020 · Updated December 19, 2020
Govt releases detailed guidelines for mass vaccination drive By IANSPublished December 15, 2020 · Updated December 15, 2020
Fake Covid-19 vaccines, remedies flooding dark web By IANSPublished December 14, 2020 · Updated December 14, 2020
Microsoft launches Covid-19 vaccine management platform By IANSPublished December 12, 2020 · Updated December 12, 2020
SII, Bharat Biotech asked to submit more data for vaccine’s emergency approval By IANSPublished December 10, 2020 · Updated December 10, 2020
Pfizer’s Covid vaccine shows favourable safety profile: US FDA By IANSPublished December 9, 2020 · Updated December 9, 2020
Biological E gets license for Ohio varsity’s Covid vaccine candidate By IANSPublished December 8, 2020
‘Vaccines expected to reach cold chain points in Delhi by Dec-end’ By IANSPublished December 6, 2020 · Updated December 6, 2020